Literature DB >> 11890645

High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach.

B M Foxwell1, S Yoshimura, J Bondeson, F M Brennan, M Feldmann.   

Abstract

BACKGROUND: Dendritic cells are the most potent antigen presenting cells and key to many aspects of the immune function. Studying the intracellular signalling mechanism used by dendritic cells would provide an insight into the functioning of these cells and give clues to strategies for immunomodulation.
METHOD: Highly efficient adenoviral infection of dendritic cells for the delivery of transgenes was obtained. These viral vectors were used to introduce IkappaB alpha into dendritic cells for the inhibition of NF-kappaB. This was used to investigate the role of NF-kappaB in dendritic cell function.
RESULTS: By blocking the NF-kappaB function a potent inhibition of the expression of costimulating molecules by dendritic cells with the concomitant loss of T cell stimulating function was demonstrated.
CONCLUSION: The use of adenoviral vectors may be a useful way of studying the role of genes in dendritic cell function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11890645      PMCID: PMC1766665          DOI: 10.1136/ard.60.90003.iii13

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

Review 1.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

Authors:  A Bender; M Sapp; G Schuler; R M Steinman; N Bhardwaj
Journal:  J Immunol Methods       Date:  1996-09-27       Impact factor: 2.303

Review 3.  Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis.

Authors:  R Thomas; P E Lipsky
Journal:  Arthritis Rheum       Date:  1996-02

4.  T cell activation determined by T cell receptor number and tunable thresholds.

Authors:  A Viola; A Lanzavecchia
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

5.  Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis.

Authors:  N J Zvaifler; R M Steinman; G Kaplan; L L Lau; M Rivelis
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 6.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 7.  MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

Authors:  R N Germain
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

8.  Methods for construction of adenovirus vectors.

Authors:  F L Graham; L Prevec
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

9.  Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

Authors:  G F Bottazzo; R Pujol-Borrell; T Hanafusa; M Feldmann
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?

Authors:  M Feldmann; E Andreakos; C Smith; J Bondeson; S Yoshimura; S Kiriakidis; C Monaco; C Gasparini; S Sacre; A Lundberg; E Paleolog; N J Horwood; F M Brennan; B M J Foxwell
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat.

Authors:  Pernilla Stridh; Melanie Thessen Hedreul; Amennai Daniel Beyeen; Milena Z Adzemovic; Hannes Laaksonen; Alan Gillett; Johan Ockinger; Monica Marta; Hans Lassmann; Kristina Becanovic; Maja Jagodic; Tomas Olsson
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

3.  Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.

Authors:  Pei Jin; Juan Zhang; Percy F Sumariwalla; Irene Ni; Brett Jorgensen; Damian Crawford; Suzanne Phillips; Marc Feldmann; H Michael Shepard; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2008-07-01       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.